BRPI1007295A8 - peptídeos antibióticos - Google Patents
peptídeos antibióticosInfo
- Publication number
- BRPI1007295A8 BRPI1007295A8 BRPI1007295A BRPI1007295A BRPI1007295A8 BR PI1007295 A8 BRPI1007295 A8 BR PI1007295A8 BR PI1007295 A BRPI1007295 A BR PI1007295A BR PI1007295 A BRPI1007295 A BR PI1007295A BR PI1007295 A8 BRPI1007295 A8 BR PI1007295A8
- Authority
- BR
- Brazil
- Prior art keywords
- antibiotic peptides
- antibiotic
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102009007381A DE102009007381A1 (de) | 2009-01-29 | 2009-01-29 | Antibiotische Peptide |
PCT/EP2010/051072 WO2010086401A1 (de) | 2009-01-29 | 2010-01-29 | Antibiotische peptide |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI1007295A BRPI1007295A (pt) | 2016-02-02 |
BRPI1007295A8 true BRPI1007295A8 (pt) | 2016-08-09 |
Family
ID=42124600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1007295A BRPI1007295A8 (pt) | 2009-01-29 | 2010-01-29 | peptídeos antibióticos |
Country Status (14)
Country | Link |
---|---|
US (3) | US8686113B2 (pt) |
EP (1) | EP2391636B1 (pt) |
JP (1) | JP2012516142A (pt) |
KR (1) | KR20110120917A (pt) |
CN (1) | CN102369210A (pt) |
AU (1) | AU2010209695A1 (pt) |
BR (1) | BRPI1007295A8 (pt) |
CA (1) | CA2751010A1 (pt) |
DE (1) | DE102009007381A1 (pt) |
IL (1) | IL214365A0 (pt) |
MX (1) | MX2011008030A (pt) |
RU (1) | RU2011135755A (pt) |
WO (1) | WO2010086401A1 (pt) |
ZA (1) | ZA201105852B (pt) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8937155B2 (en) | 2010-05-28 | 2015-01-20 | Amp Therapeutics Gmbh | Antimicrobial peptides and peptide derivatives derived from Oncopeltus fasciatus |
DE102011118029A1 (de) * | 2011-06-20 | 2012-12-20 | Universität Leipzig | Modifizierte antibiotische Peptide mit variabler systemischer Freisetzung |
CN102276691B (zh) * | 2011-08-04 | 2013-03-13 | 东北农业大学 | 一种抗菌肽及其制备方法 |
AU2012297512A1 (en) * | 2011-08-12 | 2014-03-06 | Atlantic Industries Limited | Corrugated metal plate and overhead structure incorporating same |
WO2013041663A2 (de) * | 2011-09-22 | 2013-03-28 | Amp-Therapeutics Gmbh | Modifizierte apidaecinderivate als antibiotische peptide |
WO2013064633A1 (de) | 2011-11-04 | 2013-05-10 | Amp-Therapeutics Gmbh | Oncopeltus-peptidderivate als antimikrobielle peptide |
US20130325121A1 (en) * | 2012-05-31 | 2013-12-05 | Clemson University | Protein based materials, plastic albumin devices and related methods |
JP2015529220A (ja) * | 2012-09-07 | 2015-10-05 | エイジェンシー フォー サイエンス, テクノロジー アンド リサーチ | 新規抗菌薬群としての四分岐ペプチドおよびその類似体ならびにそれらの製造 |
US9273093B2 (en) * | 2012-10-11 | 2016-03-01 | Protagonist Therapeutics, Inc. | α4β7 peptide dimer antagonists |
KR20140088837A (ko) * | 2013-01-03 | 2014-07-11 | 한미약품 주식회사 | N-말단 전하가 변형된 인슐린 분비 펩티드 유도체 |
WO2014130758A1 (en) * | 2013-02-22 | 2014-08-28 | The Trustees Of Columbia Unversity In The City Of New York | Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor atf5 |
EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
FR3005963B1 (fr) * | 2013-05-24 | 2016-02-26 | Centre Nat Rech Scient | Bacterie isolee du genre pseudoalteromonas, cyclolipopeptides, et leurs utilisations |
WO2015009701A1 (en) | 2013-07-15 | 2015-01-22 | North Carolina State University | Protease-resistant peptide ligands |
DK3143037T3 (da) | 2014-05-16 | 2021-09-20 | Protagonist Therapeutics Inc | Alpha4beta7-integrin-thioether-peptidantagonister |
RU2736637C9 (ru) | 2014-07-17 | 2021-02-08 | Протагонист Терепьютикс, Инк. | Пептидные ингибиторы рецептора интерлейкина-23 для перорального приема и их применение для лечения воспалительных заболеваний кишечника |
US9029319B1 (en) * | 2014-08-04 | 2015-05-12 | Centaur, Inc. | Water buffalo derived peptide antibiotic therapies |
WO2016054445A1 (en) | 2014-10-01 | 2016-04-07 | Protagonist Therapeutics, Inc. | Novel cyclic monomer and dimer peptides having integrin antagonist activity |
JP2017535527A (ja) | 2014-10-01 | 2017-11-30 | プロタゴニスト セラピューティクス, インコーポレイテッド | 新規のα4β7ペプチド単量体及び二量体拮抗薬 |
RU2566554C1 (ru) * | 2015-01-12 | 2015-10-27 | Федеральное бюджетное учреждение науки "Ростовский научно-исследовательский институт микробиологии и паразитологии" (ФБУН РостовНИИ микробиологии и паразитологии) | ШТАММ Stenotrophomonas maltophilia, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ АНТИГЕНА ДЛЯ ОПРЕДЕЛЕНИЯ АНТИТЕЛ К Stenotrophomonas maltophilia В БИОЛОГИЧЕСКИХ СРЕДАХ |
US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
CA3009834A1 (en) | 2015-12-30 | 2017-07-06 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
US10407468B2 (en) | 2016-03-23 | 2019-09-10 | Protagonist Therapeutics, Inc. | Methods for synthesizing α4β7 peptide antagonists |
CN113521007B (zh) * | 2016-07-01 | 2022-11-18 | 四川大学 | 抗菌肽衍生物在制备免疫佐剂中的用途 |
CA3073806A1 (en) | 2017-09-11 | 2019-03-14 | Protagonist Therapeutics, Inc. | Opioid agonist peptides and uses thereof |
WO2019157268A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
CN108864270B (zh) * | 2018-07-19 | 2021-03-30 | 四川理工学院 | 一种白蚁抗菌肽及其应用 |
EP3997105A4 (en) | 2019-07-10 | 2023-09-13 | Protagonist Therapeutics, Inc. | PEPTIDE INHIBITORS OF THE INTERLEUKIN-23 RECEPTOR AND THEIR USE IN THE TREATMENT OF INFLAMMATORY DISEASES |
CN118005737A (zh) | 2020-01-15 | 2024-05-10 | 詹森生物科技公司 | 介白素-23受体的肽抑制剂及其治疗炎性疾病的用途 |
CA3202226A1 (en) | 2020-11-20 | 2022-05-27 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
WO2022132194A2 (en) * | 2020-12-15 | 2022-06-23 | Neubase Therapeutics, Inc. | Oligonucleotide analogue therapeutics for treatment of neuromuscular disease |
CN113549137B (zh) * | 2021-07-09 | 2022-04-19 | 东北农业大学 | 一种靶向革兰氏阴性菌的富脯氨酸抗菌肽Pyr-2及其制备方法与应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5028A (en) * | 1847-03-20 | monohot | ||
ATE107317T1 (de) | 1987-07-01 | 1994-07-15 | Plant Genetic Systems Nv | Bakteriozide und/oder bakteriostatische peptide, verfahren zu ihrer isolierung, herstellung und verwendung. |
US5466671A (en) | 1994-03-02 | 1995-11-14 | Sloan-Kettering Institute For Cancer Research | Apidaecin-type peptide antibiotics with improved activities and/or different antibacterial spectrum |
EP1194548A4 (en) | 1999-06-23 | 2003-06-18 | Wistar Inst | NOVEL PYRRHOCORICIN-DERIVED PEPTIDES AND METHODS OF IMPLEMENTING THE SAME |
US20030104622A1 (en) * | 1999-09-01 | 2003-06-05 | Robbins Paul D. | Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses |
US20020041898A1 (en) | 2000-01-05 | 2002-04-11 | Unger Evan C. | Novel targeted delivery systems for bioactive agents |
WO2002079467A2 (en) | 2001-03-29 | 2002-10-10 | Københavns Universitet | Antibiotic-free bacterial strain selection with antisense molecules |
WO2003062266A2 (en) | 2002-01-22 | 2003-07-31 | Intrabiotics Pharmaceuticals, Inc. | Hybrid synthetic method for antimicrobial peptides |
US20060264353A1 (en) * | 2002-03-21 | 2006-11-23 | Maxey Kirk M | Prostaglandin f2alpha analogs and their use in combination with antimicrobial proteins for the treatment of glaucoma and intraocular hypertension |
US20050058603A1 (en) | 2003-05-02 | 2005-03-17 | Case Western Reserve University | Drug delivery system based on polymer nanoshells |
US20050282755A1 (en) * | 2004-03-18 | 2005-12-22 | Ansata Therapeutics, Inc. | Compositions having antimicrobial activity and uses thereof |
DE102007036128A1 (de) | 2007-07-23 | 2009-02-12 | Universität Leipzig | Antibiotische Peptide |
-
2009
- 2009-01-29 DE DE102009007381A patent/DE102009007381A1/de not_active Withdrawn
-
2010
- 2010-01-29 WO PCT/EP2010/051072 patent/WO2010086401A1/de active Application Filing
- 2010-01-29 EP EP10705318.3A patent/EP2391636B1/de not_active Not-in-force
- 2010-01-29 JP JP2011546854A patent/JP2012516142A/ja active Pending
- 2010-01-29 CN CN2010800158123A patent/CN102369210A/zh active Pending
- 2010-01-29 MX MX2011008030A patent/MX2011008030A/es unknown
- 2010-01-29 US US13/147,095 patent/US8686113B2/en active Active
- 2010-01-29 AU AU2010209695A patent/AU2010209695A1/en not_active Abandoned
- 2010-01-29 BR BRPI1007295A patent/BRPI1007295A8/pt not_active IP Right Cessation
- 2010-01-29 CA CA2751010A patent/CA2751010A1/en not_active Abandoned
- 2010-01-29 RU RU2011135755/04A patent/RU2011135755A/ru not_active Application Discontinuation
- 2010-01-29 KR KR1020117019813A patent/KR20110120917A/ko not_active Application Discontinuation
-
2011
- 2011-07-31 IL IL214365A patent/IL214365A0/en unknown
- 2011-08-10 ZA ZA2011/05852A patent/ZA201105852B/en unknown
-
2014
- 2014-02-25 US US14/188,913 patent/US20150299256A1/en not_active Abandoned
-
2016
- 2016-08-04 US US15/228,116 patent/US20170114096A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US8686113B2 (en) | 2014-04-01 |
US20150299256A1 (en) | 2015-10-22 |
EP2391636A1 (de) | 2011-12-07 |
JP2012516142A (ja) | 2012-07-19 |
CA2751010A1 (en) | 2010-08-05 |
EP2391636B1 (de) | 2017-09-27 |
US20120021975A1 (en) | 2012-01-26 |
DE102009007381A1 (de) | 2010-08-05 |
MX2011008030A (es) | 2011-09-27 |
KR20110120917A (ko) | 2011-11-04 |
BRPI1007295A (pt) | 2016-02-02 |
AU2010209695A1 (en) | 2011-09-15 |
ZA201105852B (en) | 2013-03-27 |
US20170114096A1 (en) | 2017-04-27 |
WO2010086401A1 (de) | 2010-08-05 |
IL214365A0 (en) | 2011-09-27 |
RU2011135755A (ru) | 2013-03-10 |
CN102369210A (zh) | 2012-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1007295A8 (pt) | peptídeos antibióticos | |
BRPI0814587A2 (pt) | Peptídeos antibióticos | |
DK2462134T3 (da) | N1-sulfonyl-5-fluorpyrimidinonderivater | |
BRPI1013989A2 (pt) | pneumático | |
DK2414015T3 (da) | Laryngoskopsystem | |
DE112010004215A5 (de) | Hydrostataktor | |
DK2411442T4 (da) | Umættet polyesterresin | |
BRPI1011967A2 (pt) | pneumático | |
BRPI1008827A2 (pt) | deisobutenizador | |
BRPI1014968A2 (pt) | subalargador | |
DE112010002728A5 (de) | Turboinhalator | |
DE112009005323A5 (de) | Hebelarmprüfmaschine | |
BRPI1013720A2 (pt) | pneumático | |
BRPI1007884A2 (pt) | derivados de actagardina | |
DE112010004249A5 (de) | Spindelaktor | |
DE112009005462T8 (de) | Lenkungsssteuervorrichtung | |
BR112012004964A2 (pt) | girocóptero | |
BRPI1008070A2 (pt) | tricianoboratos | |
BRPI1010661A2 (pt) | peptídeo | |
BRPI1008662A2 (pt) | pneumático | |
FR2947857B1 (fr) | Agencement de deshuileur | |
DE112010004865T8 (de) | Lamellennassreibkupplung | |
BRPI1007486A2 (pt) | pneumático | |
DE112010003255A5 (de) | Fördergutverteiler | |
BRPI1010159A2 (pt) | bistuti |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B25E | Requested change of name of applicant rejected |
Owner name: AMP-THERAPEUTICS GMBH AND CO. KG (DE) |
|
B15K | Others concerning applications: alteration of classification |
Ipc: C07K 7/08 (2006.01), A01N 47/44 (2006.01), A61K 38 |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |